About

Erythropoietin (EPO) is a crucial glycoprotein hormone naturally synthesized primarily by the kidneys, playing a pivotal role in stimulating erythropoiesis, the process of red blood cell production within the bone marrow. Recombinant human erythropoietin (rHuEPO) represents a bioengineered version of this hormone, widely employed therapeutically to manage anemia stemming from various underlying conditions, most notably chronic kidney disease, chemotherapy-induced anemia in cancer patients, and certain other myelosuppressive states. Its therapeutic action is initiated by binding to specific erythropoietin receptors located on erythroid progenitor cells, thereby promoting their proliferation, differentiation, and maturation into functional red blood cells. This targeted stimulation effectively elevates hemoglobin levels, significantly diminishes the necessity for blood transfusions, and substantially alleviates debilitating symptoms of anemia, such as profound fatigue, weakness, and dyspnea, thereby enhancing patient quality of life.

Uses

Anemia associated with chronic kidney disease.
Anemia in cancer patients receiving chemotherapy.
Anemia in zidovudine-treated HIV-infected patients.
Reduction of allogeneic blood transfusions in surgery.

Directions For Use

Administered via subcutaneous or intravenous injection, typically by a healthcare professional. Dosage and frequency depend on the patient's condition and response.

Benefits

Increases red blood cell count and hemoglobin levels.
Reduces the need for blood transfusions.
Improves symptoms of anemia (e.g., fatigue).
Enhances quality of life for anemic patients.
Supports recovery from certain medical treatments.
Helps manage chronic anemia effectively.

Side Effects

Hypertension
Headache
Fever
Nausea
Vomiting
Diarrhea
Injection site pain
Thrombosis (blood clots)
Seizures
Rash
Flu-like symptoms
Pure red cell aplasia (rare)

Safety Measures

Alcohol - No specific interaction with alcohol is known, but maintaining overall health is important.
Pregnancy - Use during pregnancy only if clearly needed, as animal studies have shown adverse effects. Consult a doctor.
Breastfeeding - It is unknown if this medication passes into breast milk. Caution should be exercised when administered to a breastfeeding woman.
Liver - Use with caution in patients with severe liver disease, as liver function may affect drug metabolism.
Kidney - Primarily used for anemia in chronic kidney disease, but careful monitoring of blood pressure and hemoglobin is crucial.
Lung - No specific direct lung effects, but patients with pre-existing cardiovascular or thrombotic risk factors should be monitored.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location